Oxford Medical Products

BaroSense

This company develops minimally invasive medical devices and implants for the treatment of obesity in adult patients.

Allurion Technologies

This digital health company manufactures a swallowable gastric balloon and weight management software for patients seeking non-surgical obesity treatment.

Prolynx

The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

BLEED DETECTION SYSTEM

This company develops an ingestible sensor capsule and receiver to detect upper gastrointestinal bleeding for healthcare providers treating adult patients.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Alveus Therapeutics

This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.